What is Jazz Pharmaceuticals's equity method investments?

Jazz Pharmaceuticals (JAZZ) reported equity method investments of $4.3M in Q1 2026.

How has Jazz Pharmaceuticals's equity method investments changed year-over-year?

Jazz Pharmaceuticals's equity method investments decreased by 0.0% year-over-year, from $4.3M to $4.3M.

What is the long-term trend for Jazz Pharmaceuticals's equity method investments?

Over 3 years (2022 to 2025), Jazz Pharmaceuticals's equity method investments has grown at a -7.9% compound annual growth rate (CAGR), from $5.5M to $4.3M.

Jazz Pharmaceuticals JAZZ Equity Method Investments

Equity Method Investments at other companies

BridgeBio PharmaBBIO

$61.53M-52.0%

Royalty PharmaRPRX

$265.7M-21.0%

Eli LillyLLY

$3.12B-3.3%

ResMedRMD

——

Other financials

Income statement

See full

Revenue$1.1B+19.1%

Operating income$336.6M+702%

Net income$293.1M+417%

EPS (diluted)$4.43+391%

Balance sheet

See full

Cash & equivalents$667.5M-64.1%

Total debt$5.4B-0.1%

Total equity$4.5B+8.6%

Total assets$11.9B+2.8%

Cash flow

See full

Operating cash flow$408.2M-5.0%

CapEx$19.7M+41.7%

Free cash flow$388.5M-6.6%

Valuation

See full

Market cap$14.11B+54.4%

Enterprise value$18.85B+47.7%

P/S3.2×+0.9×

Profitability

See full

Operating margin-11.9%-28.1pp

Net margin-8.9%-20.5pp

FCF margin28.6%-8.6pp

Returns & leverage

See full

Return on equity-9.1%-21.2pp

Debt / equity1.2×-0.1×

Current ratio2×-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Jazz Pharmaceuticals's equity method investments?: Jazz Pharmaceuticals (JAZZ) reported equity method investments of $4.3M in Q1 2026.
How has Jazz Pharmaceuticals's equity method investments changed year-over-year?: Jazz Pharmaceuticals's equity method investments decreased by 0.0% year-over-year, from $4.3M to $4.3M.
What is the long-term trend for Jazz Pharmaceuticals's equity method investments?: Over 3 years (2022 to 2025), Jazz Pharmaceuticals's equity method investments has grown at a -7.9% compound annual growth rate (CAGR), from $5.5M to $4.3M.